NKT Therapeutics
A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
2
Funding Rounds
$12.0m
Money raised
Overview
A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
- Website:
Funding
Funding series
Funding Series Analysis
The company NKT Therapeutics has raised a total of $12m in funding over 2 rounds.
Key Insights:
- NKT Therapeutics funding round, August 2010: $4m
- NKT Therapeutics Series A round: $8m
NKT Therapeutics funding round, August 2010
$4m
NKT Therapeutics Series A round
$8m
Industries
NKT Therapeutics is active in the following industries: